NO154131B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. Download PDFInfo
- Publication number
- NO154131B NO154131B NO792659A NO792659A NO154131B NO 154131 B NO154131 B NO 154131B NO 792659 A NO792659 A NO 792659A NO 792659 A NO792659 A NO 792659A NO 154131 B NO154131 B NO 154131B
- Authority
- NO
- Norway
- Prior art keywords
- group
- general formula
- butoxy
- nitro
- melting point
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 6
- 238000000034 method Methods 0.000 title claims description 5
- 230000001225 therapeutic effect Effects 0.000 title description 2
- -1 quinazolin-4-on-yl Chemical group 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 9
- 239000011541 reaction mixture Substances 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000005606 carbostyryl group Chemical group 0.000 claims description 4
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 230000000269 nucleophilic effect Effects 0.000 claims description 4
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000006798 ring closing metathesis reaction Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 3
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000004104 aryloxy group Chemical group 0.000 claims description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 125000005059 halophenyl group Chemical group 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 125000004464 hydroxyphenyl group Chemical group 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 125000005493 quinolyl group Chemical group 0.000 claims description 2
- 125000006839 xylylene group Chemical group 0.000 claims description 2
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 238000002844 melting Methods 0.000 description 44
- 230000008018 melting Effects 0.000 description 44
- WFDIJRYMOXRFFG-UHFFFAOYSA-N acetic acid anhydride Natural products CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 14
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 13
- 229960000583 acetic acid Drugs 0.000 description 12
- 238000009835 boiling Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000012362 glacial acetic acid Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 229910000027 potassium carbonate Inorganic materials 0.000 description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- RGHZFRRLCRAWPU-UHFFFAOYSA-N methyl 3-(5-hydroxy-2-nitrophenyl)prop-2-enoate Chemical compound COC(=O)C=CC1=CC(O)=CC=C1[N+]([O-])=O RGHZFRRLCRAWPU-UHFFFAOYSA-N 0.000 description 5
- 150000002828 nitro derivatives Chemical class 0.000 description 5
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- UNSRBMRZUQKJMV-UHFFFAOYSA-N 2-nitro-5-(4-pyridin-2-ylsulfanylbutoxy)benzaldehyde Chemical compound C1=C(C=O)C([N+](=O)[O-])=CC=C1OCCCCSC1=CC=CC=N1 UNSRBMRZUQKJMV-UHFFFAOYSA-N 0.000 description 3
- AJRIOFDACOMVOP-UHFFFAOYSA-N 5-(4-bromobutoxy)-2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(OCCCCBr)C=C1C=O AJRIOFDACOMVOP-UHFFFAOYSA-N 0.000 description 3
- BSLNASIIJWWYOU-UHFFFAOYSA-N COC(C=CC(C=C(C=C1)OCCCCS(C(C=C2)=CC(Cl)=C2Cl)=O)=C1[N+]([O-])=O)=O Chemical compound COC(C=CC(C=C(C=C1)OCCCCS(C(C=C2)=CC(Cl)=C2Cl)=O)=C1[N+]([O-])=O)=O BSLNASIIJWWYOU-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940046892 lead acetate Drugs 0.000 description 3
- 239000011981 lindlar catalyst Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- KHYJWJQEQGMQOT-UHFFFAOYSA-N methyl 3-[2-nitro-5-(4-pyridin-2-ylsulfonylbutoxy)phenyl]prop-2-enoate Chemical compound COC(C=CC1=C(C=CC(=C1)OCCCCS(=O)(=O)C1=NC=CC=C1)[N+](=O)[O-])=O KHYJWJQEQGMQOT-UHFFFAOYSA-N 0.000 description 3
- RIJAFJFYYMYUJM-UHFFFAOYSA-N methyl 3-[5-(4-bromobutoxy)-2-nitrophenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC(OCCCCBr)=CC=C1[N+]([O-])=O RIJAFJFYYMYUJM-UHFFFAOYSA-N 0.000 description 3
- 235000011056 potassium acetate Nutrition 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- BXXWFOGWXLJPPA-UHFFFAOYSA-N 2,3-dibromobutane Chemical compound CC(Br)C(C)Br BXXWFOGWXLJPPA-UHFFFAOYSA-N 0.000 description 2
- ZHSJYOOSMOOIGM-UHFFFAOYSA-N 2-amino-5-(4-pyridin-2-ylsulfonylbutoxy)benzaldehyde Chemical compound C1=C(C=O)C(N)=CC=C1OCCCCS(=O)(=O)C1=CC=CC=N1 ZHSJYOOSMOOIGM-UHFFFAOYSA-N 0.000 description 2
- KBVIQLRCIJFIMF-UHFFFAOYSA-N 6-(4-pyridin-2-ylsulfonylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCS(=O)(=O)C1=CC=CC=N1 KBVIQLRCIJFIMF-UHFFFAOYSA-N 0.000 description 2
- RWJPWMCCTIJSSR-UHFFFAOYSA-N COC(=O)C=CC1=C(C=CC(=C1)OCCCCS(=O)C2=CC(=C(C=C2)Cl)Cl)N Chemical compound COC(=O)C=CC1=C(C=CC(=C1)OCCCCS(=O)C2=CC(=C(C=C2)Cl)Cl)N RWJPWMCCTIJSSR-UHFFFAOYSA-N 0.000 description 2
- 229910021554 Chromium(II) chloride Inorganic materials 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- XBWRJSSJWDOUSJ-UHFFFAOYSA-L chromium(ii) chloride Chemical compound Cl[Cr]Cl XBWRJSSJWDOUSJ-UHFFFAOYSA-L 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- ILAIRHNIGUVLCZ-UHFFFAOYSA-N methyl 3-[2-nitro-5-(4-pyridin-2-ylsulfanylbutoxy)phenyl]prop-2-enoate Chemical compound COC(C=CC1=C(C=CC(=C1)OCCCCSC1=NC=CC=C1)[N+](=O)[O-])=O ILAIRHNIGUVLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- WHMDPDGBKYUEMW-UHFFFAOYSA-N pyridine-2-thiol Chemical compound SC1=CC=CC=N1 WHMDPDGBKYUEMW-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- ULTHEAFYOOPTTB-UHFFFAOYSA-N 1,4-dibromobutane Chemical compound BrCCCCBr ULTHEAFYOOPTTB-UHFFFAOYSA-N 0.000 description 1
- UEEMWZOYWPDOKS-UHFFFAOYSA-N 2-nitro-5-(4-pyridin-2-ylsulfonylbutoxy)benzaldehyde Chemical compound C1=C(C=O)C([N+](=O)[O-])=CC=C1OCCCCS(=O)(=O)C1=CC=CC=N1 UEEMWZOYWPDOKS-UHFFFAOYSA-N 0.000 description 1
- SPWWWLCTUNXBRR-UHFFFAOYSA-N 3-(5-hydroxy-2-nitrophenyl)prop-2-enoic acid Chemical compound OC(=O)C=CC1=CC(O)=CC=C1[N+]([O-])=O SPWWWLCTUNXBRR-UHFFFAOYSA-N 0.000 description 1
- ADSNHKTXYJZXDF-UHFFFAOYSA-N 3-hydroxy-2-nitrobenzaldehyde Chemical compound OC1=CC=CC(C=O)=C1[N+]([O-])=O ADSNHKTXYJZXDF-UHFFFAOYSA-N 0.000 description 1
- SRGYBRHWRBDUJM-UHFFFAOYSA-N 4-(4-bromobutylsulfanyl)-1,2-dichlorobenzene Chemical compound ClC1=CC=C(SCCCCBr)C=C1Cl SRGYBRHWRBDUJM-UHFFFAOYSA-N 0.000 description 1
- ICFZWESBQTTYOC-UHFFFAOYSA-N 4-(4-bromobutylsulfinyl)-1,2-dichlorobenzene Chemical compound ClC1=CC=C(S(=O)CCCCBr)C=C1Cl ICFZWESBQTTYOC-UHFFFAOYSA-N 0.000 description 1
- UTTJAIFHRUAFED-UHFFFAOYSA-N 5-hydroxy-3,4-dihydro-2(1h)-quinolinone Chemical compound N1C(=O)CCC2=C1C=CC=C2O UTTJAIFHRUAFED-UHFFFAOYSA-N 0.000 description 1
- WMNKNHUCSKDKMK-UHFFFAOYSA-N 6-(4-bromobutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound N1C(=O)CCC2=CC(OCCCCBr)=CC=C21 WMNKNHUCSKDKMK-UHFFFAOYSA-N 0.000 description 1
- VNKUIWUYOIQBMP-UHFFFAOYSA-N 6-(4-phenylsulfanylbutoxy)-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCCCSC1=CC=CC=C1 VNKUIWUYOIQBMP-UHFFFAOYSA-N 0.000 description 1
- UXBIFQZFTVFCDC-UHFFFAOYSA-N 6-(4-pyridin-2-ylsulfonylbutoxy)-1h-quinolin-2-one Chemical compound C1=CC2=NC(O)=CC=C2C=C1OCCCCS(=O)(=O)C1=CC=CC=N1 UXBIFQZFTVFCDC-UHFFFAOYSA-N 0.000 description 1
- FFOAMIRPYWTXQX-UHFFFAOYSA-N 6-(4-quinolin-2-ylsulfinylbutoxy)-1h-quinolin-2-one Chemical compound C1=CC=CC2=NC(S(CCCCOC=3C=C4C=CC(=O)NC4=CC=3)=O)=CC=C21 FFOAMIRPYWTXQX-UHFFFAOYSA-N 0.000 description 1
- DUDLVNRPJPQAPX-UHFFFAOYSA-N 6-[2-(benzenesulfinyl)ethoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C=1C=C2NC(=O)CCC2=CC=1OCCS(=O)C1=CC=CC=C1 DUDLVNRPJPQAPX-UHFFFAOYSA-N 0.000 description 1
- SXSYHNCKTQPJPL-UHFFFAOYSA-N 6-[4-(2-methoxyphenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound COC1=CC=CC=C1S(=O)CCCCOC1=CC=C(NC(=O)CC2)C2=C1 SXSYHNCKTQPJPL-UHFFFAOYSA-N 0.000 description 1
- UURXBTHJZQYWEK-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfanylbutoxy]-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1SCCCCOC1=CC=C(NC(=O)C=C2)C2=C1 UURXBTHJZQYWEK-UHFFFAOYSA-N 0.000 description 1
- OLKNUHLCNLDYJN-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfanylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1SCCCCOC1=CC=C(NC(=O)CC2)C2=C1 OLKNUHLCNLDYJN-UHFFFAOYSA-N 0.000 description 1
- USKSSUIWVBMHGS-UHFFFAOYSA-N 6-[4-(3,4-dichlorophenyl)sulfinylbutoxy]-3,4-dihydro-1h-quinolin-2-one Chemical compound C1=C2CCC(O)=NC2=CC=C1OCCCCS(=O)C1=CC=C(Cl)C(Cl)=C1 USKSSUIWVBMHGS-UHFFFAOYSA-N 0.000 description 1
- KSUKFRAZFFLINQ-UHFFFAOYSA-N 6-[4-(benzenesulfinyl)butoxy]-4-methyl-1h-quinolin-2-one Chemical compound C1=C2C(C)=CC(=O)NC2=CC=C1OCCCCS(=O)C1=CC=CC=C1 KSUKFRAZFFLINQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- BQFYGQSOQVOJAS-UHFFFAOYSA-N C(O)(O)=O.[N+](=O)([O-])C1=C(C=O)C=C(C=C1)O Chemical compound C(O)(O)=O.[N+](=O)([O-])C1=C(C=O)C=C(C=C1)O BQFYGQSOQVOJAS-UHFFFAOYSA-N 0.000 description 1
- ZWSJTKSIRMBTRY-UHFFFAOYSA-N CCC(COC(=CC1=CC(=CC=C1)S(=O)C2=CC(=C(C=C2)Cl)Cl)C(=O)OC)[N+](=O)[O-] Chemical compound CCC(COC(=CC1=CC(=CC=C1)S(=O)C2=CC(=C(C=C2)Cl)Cl)C(=O)OC)[N+](=O)[O-] ZWSJTKSIRMBTRY-UHFFFAOYSA-N 0.000 description 1
- CRXZROMIWRFKST-UHFFFAOYSA-N COC(=O)C=CC1=C(C=CC(=C1)OCCCCSC2=CC(=C(C=C2)Cl)Cl)[N+](=O)[O-] Chemical compound COC(=O)C=CC1=C(C=CC(=C1)OCCCCSC2=CC(=C(C=C2)Cl)Cl)[N+](=O)[O-] CRXZROMIWRFKST-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 244000154870 Viola adunca Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 238000005899 aromatization reaction Methods 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000009090 positive inotropic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 125000003375 sulfoxide group Chemical group 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- AXZWODMDQAVCJE-UHFFFAOYSA-L tin(II) chloride (anhydrous) Chemical compound [Cl-].[Cl-].[Sn+2] AXZWODMDQAVCJE-UHFFFAOYSA-L 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Description
I patent 152839 (ansøkning 79.0521) er beskrevet frem-gangsmåter for fremstilling av bl.a. karbostyrilderivater med den generelle formel In patent 152839 (application 79.0521) procedures for the production of, among other things, are described. carbostyryl derivatives of the general formula
hvor where
W betyr en eventuelt med en metylgruppe substituert vinylen- W means a vinylene optionally substituted with a methyl group-
gruppe eller en etylengruppe, group or an ethylene group,
m betyr tallet 0, 1 eller 2, m means the number 0, 1 or 2,
D betyr en lineær alkylengruppe med 2 til 6 karbonatomer, en 2-hydroksy-n-propylengruppe eller en xylylengruppe, D means a linear alkylene group of 2 to 6 carbon atoms, a 2-hydroxy-n-propylene group or a xylylene group,
R2 betyr en cykloheksy1-, benzyl-, naftyl-, pyridyl-, pyrimidyl-, 1,2,4-triazolyl-, pyridyl-oksyd-, furfuryl-, trifenylmetyl-, R 2 means a cyclohexy1-, benzyl-, naphthyl-, pyridyl-, pyrimidyl-, 1,2,4-triazolyl-, pyridyl-oxide-, furfuryl-, triphenylmethyl-,
kinolyl-, benzimidazolyl-, benztiazolyl-, kinazolin-4-on-yl-, 4,5-bis- (p-klorfenyl)-oksazol-2-yl-, N-metyl-N-cykloheksylamino-karbonylmety1- eller aminoiminometylgruppe, en eventuelt med en karboksyl-, hydroksy-, metoksy-, amino-, acetylamino-, nitro-, cykloheksyl- eller fenylgruppe substituert fenylgruppe, quinolyl-, benzimidazolyl-, benzthiazolyl-, quinazolin-4-on-yl-, 4,5-bis-(p-chlorophenyl)-oxazol-2-yl-, N-methyl-N-cyclohexylamino-carbonylmethyl- or aminoiminomethyl group, a phenyl group optionally substituted with a carboxyl, hydroxy, methoxy, amino, acetylamino, nitro, cyclohexyl or phenyl group,
en med halogenatomer og/eller alkylgrupper med 1-4 karbonatomer mono- eller disubstituert fenylgruppe, en med to halogenatomer eller med to alkylgrupper med 1-4 karbonatomer substituert one with halogen atoms and/or alkyl groups with 1-4 carbon atoms mono- or disubstituted phenyl group, one with two halogen atoms or with two alkyl groups with 1-4 carbon atoms substituted
hydroksyfenyl-, halogenfenyl- eller aminofenylgruppe, hydroxyphenyl, halophenyl or aminophenyl group,
R^ betyr et hydrogen- eller bromatom eller en acetylamino- eller nitrogruppe, og R^ means a hydrogen or bromine atom or an acetylamino or nitro group, and
resten R„-S0 -D-0- er i 6- eller 7-stilling. the remainder R„-S0 -D-0- is in the 6- or 7-position.
/ m J/ m J
Forbindelsene med den ovenstående generelle formel The compounds with the above general formula
I oppviser verdifulle terapeutiske egenskaper, ved siden av en positiv inotrop virkning, særlig anti trombotiske egenskaper, slik som vist i hovedpatentet. In addition to a positive inotropic effect, it exhibits valuable therapeutic properties, particularly anti-thrombotic properties, as shown in the main patent.
Det er nu funnet at karbostyrilderivatene med den generelle formel I også kan fremstilles efter følgende frem-gangmåter: a) Ringslutning av en eventuelt i reaksjonsblandingen dannet forbindelse med den generelle formel It has now been found that the carbostyryl derivatives with the general formula I can also be prepared according to the following procedures: a) Ring closure of a possibly in the reaction mixture formed connection with the general formula
hvor where
D, W, R2' R3 og m er som ovenfor angitt, og D, W, R2, R3 and m are as indicated above, and
Z betyr en nukleofil, avspaltbar gruppe så som en hydroksygruppe, et halogenatom, en alkoksy-, aryloksy- eller aralkoksygruppe. Z means a nucleophilic leaving group such as a hydroxy group, a halogen atom, an alkoxy, aryloxy or aralkyl group.
Ringslutningen foretas fortrinnsvis i nærvær av et kondensasjonsmiddel så som svovelsyre, konsentrert saltsyre, fosforsyre eller tionylklorid, hensiktsmessig i et oppløsnings-middel så som iseddik, tetrahydrofuran, dioksan, kloroform, toluen, etanol eller et overskudd av det anvendte kondensasjonsmiddel ved forhøyet temperatur, f.eks. ved temperaturer mellom 50 og 200°C, fortrinnsvis ved temperaturer mellom 80 og 150°C. Omsetningen kan imidlertid også utføres uten oppløsningsmiddel og/eller kondensasjonsmiddel. The cyclization is preferably carried out in the presence of a condensing agent such as sulfuric acid, concentrated hydrochloric acid, phosphoric acid or thionyl chloride, suitably in a solvent such as glacial acetic acid, tetrahydrofuran, dioxane, chloroform, toluene, ethanol or an excess of the used condensing agent at an elevated temperature, f .ex. at temperatures between 50 and 200°C, preferably at temperatures between 80 and 150°C. However, the reaction can also be carried out without solvent and/or condensing agent.
Det er her ikke nødvendig å isolere en som utgangs-materiale anvendt forbindelse med den generelle formel II. It is not necessary here to isolate a compound of the general formula II used as starting material.
Denne kan snarere fremstilles in situ fra den tilsvarende nitroforbindelse, f.eks. ved reduksjon av nitrogruppen med hydrogen i nærvær av en hydrogeneringskatalysator så som palladium/kull, palladium/kalsiumkarbonat eller palladium/kalsiumkarbonat + blyacetat (Lindlar-katalysator), ved reduksjon med metaller så This can rather be prepared in situ from the corresponding nitro compound, e.g. by reduction of the nitro group with hydrogen in the presence of a hydrogenation catalyst such as palladium/charcoal, palladium/calcium carbonate or palladium/calcium carbonate + lead acetate (Lindlar catalyst), by reduction with metals such
som jern, tinn eller sink i nærvær av en syre, ved reduksjon med salter så som jern(II)sulfat, tinn(II)klorid, krom(II)klorid eller natriumditionitt eller ved reduksjon med hydrazin i nærvær av Raney-nikkel. such as iron, tin or zinc in the presence of an acid, by reduction with salts such as iron(II) sulphate, tin(II) chloride, chromium(II) chloride or sodium dithionite or by reduction with hydrazine in the presence of Raney nickel.
Hvis m i en tilsvarende nitroforbindelse betyr tallet 1, foretas reduksjonen av nitrogruppen hensiktsmessig med den ekvivalente mengde av det anvendte reduksjonsmiddel, f.eks. If m in a corresponding nitro compound means the number 1, the reduction of the nitro group is suitably carried out with the equivalent amount of the reducing agent used, e.g.
med et metallsalt så som jern(II)sulfat, tinn(II)klorid, krom(II)-klorid eller natriumditionitt, eller med hydrogen i nærvær av en desaktivert hydrogeneringskatalysator, f.eks. i nærvær av palladium/kalsiumkarbonat + blyacetat. Hvis man f.eks. foretar reduksjonen i nærvær av palladium/kull, vil sulfoksydgruppen delvis bli medredusert. with a metal salt such as iron (II) sulfate, stannous (II) chloride, chromium (II) chloride or sodium dithionite, or with hydrogen in the presence of a deactivated hydrogenation catalyst, e.g. in the presence of palladium/calcium carbonate + lead acetate. If you e.g. if the reduction is carried out in the presence of palladium/charcoal, the sulfoxide group will be partially co-reduced.
Hvis W i den tilsvarende nitroforbindelse dessuten Moreover, if W in the corresponding nitro compound
betyr en vinylengruppe, kan denne gruppe, særlig når reduksjonen foretas med katalytisk aktivert hydrogen, f.eks. med hydrogen i nærvær av palladium/kull, hydrogeneres til den tilsvarende etylengruppe. b) For fremstilling av forbindelser med den generelle formel I hvor m betyr tallet 2: means a vinylene group, this group can, especially when the reduction is carried out with catalytically activated hydrogen, e.g. with hydrogen in the presence of palladium/charcoal, is hydrogenated to the corresponding ethylene group. b) For the preparation of compounds of the general formula I where m means the number 2:
Omsetning av et karbostyril med den generelle formel Reaction of a carbostyril with the general formula
hvor D, W og R3 er som ovenfor angitt, og where D, W and R 3 are as above indicated, and
Y betyr en nukleofil, avspaltbar gruppe så som et halogenatom eller en sulfonsyrerest, f.eks. et klor-, brom- eller jodatom, en p-toluensulfonyloksy- eller metansulfonyloksygruppe, med et metallsalt med den generelle formel Y means a nucleophilic, cleavable group such as a halogen atom or a sulphonic acid residue, e.g. a chlorine, bromine or iodine atom, a p-toluenesulfonyloxy or methanesulfonyloxy group, with a metal salt of the general formula
hvor R_ er som ovenfor angitt, og where R_ is as above indicated, and
Me betyr et alkali- metallatom, og Me^ betyr et jordalkali-metallatom så som henholdsvis et natrium- eller kaliumatom eller et kalsiumatom. Me means an alkali metal atom, and Me^ means an alkaline earth metal atom such as a sodium or potassium atom or a calcium atom, respectively.
Omsetningen foretas hensiktsmessig i et egnet oppløsnings-middel så som dioksan, tetrahydrofuran, kloroform eller toluen, fortrinnsvis i et vandig aprotisk oppløsningsmiddel så som aceton, dimetylformamid eller dimetylsulfoksyd, eventuelt i nærvær av en alkalibase så som natriumkarbonat, kaliumkarbonat eller natriumhydroksyd ved temperaturer mellom 0°C og det anvendte oppløsningsmiddels koketemperatur, f.eks. ved temperaturer mellom 0 og 100°C, fortrinnsvis ved temperaturer mellom 10 og 50°C. Omsetningen kan også utføres uten oppløsningsmiddel. c) For fremstilling av forbindelser med den generelle formel I hvor W betyr en vinylengruppe og m betyr tallet 0 eller 2: Ringslutning av en eventuelt i reaksjonsblandingen dannet forbindelse med den generelle formel The reaction is conveniently carried out in a suitable solvent such as dioxane, tetrahydrofuran, chloroform or toluene, preferably in an aqueous aprotic solvent such as acetone, dimethylformamide or dimethylsulfoxide, optionally in the presence of an alkali base such as sodium carbonate, potassium carbonate or sodium hydroxide at temperatures between 0 °C and the boiling temperature of the solvent used, e.g. at temperatures between 0 and 100°C, preferably at temperatures between 10 and 50°C. The reaction can also be carried out without a solvent. c) For the preparation of compounds with the general formula I where W means a vinylene group and m means the number 0 or 2: Ring closure of an optionally in the reaction mixture formed connection with the general formula
hvor & 2' R3' D og m er som ovenfor angitt, eller et acetal derav. where & 2' R 3' D and m are as indicated above, or an acetal thereof.
Ringslutningen foretas hensiktsmessig i iseddik eller eddiksyreanhydrid i nærvær av et alkaliacetat så som natrium-eller kaliumacetat ved temperaturer mellom 80 og 160°C, fortrinnsvis ved reaksjonsblandingens koketemperatur, f.eks. ved temperaturer mellom 118 og 140°C. En forbindelse med den generelle formel V fremstilles hensiktsmessig ved reduksjon av en tilsvarende nitroforbindelse i nærvær av acetylklorid eller eddiksyreanhydrid, og det er ikke nødvendig å isolere den. The cyclization is suitably carried out in glacial acetic acid or acetic anhydride in the presence of an alkali acetate such as sodium or potassium acetate at temperatures between 80 and 160°C, preferably at the boiling temperature of the reaction mixture, e.g. at temperatures between 118 and 140°C. A compound of the general formula V is conveniently prepared by reduction of a corresponding nitro compound in the presence of acetyl chloride or acetic anhydride, and it is not necessary to isolate it.
De som utgangsmaterialer anvendte forbindelser med Those used as starting materials compounds with
de generelle formler II til Vier delvis kjent fra litteraturen eller kan fremstilles ved i og for seg kjente metoder. the general formulas II to Vier are partially known from the literature or can be prepared by methods known per se.
Således får man en forbindelse med den generelle Thus one gets a connection with the general
formel II ved reduksjon av den tilsvarende nitroforbindelse, formula II by reduction of the corresponding nitro compound,
som man på sin side får ved alkylering av en tilsvarende 2-nitro-5-hydroksyforbindelse med et tilsvarende a,w-dihalogenalkan, påfølgende omsetning med en tilsvarende merkaptoforbindelse og eventuelt påfølgende oksydasjon med hydrogenperoksyd. which in turn is obtained by alkylation of a corresponding 2-nitro-5-hydroxy compound with a corresponding a,w-dihaloalkane, subsequent reaction with a corresponding mercapto compound and possibly subsequent oxidation with hydrogen peroxide.
En utgangsforbindelse med den generelle formel III A starting compound of the general formula III
får man ved omsetning av et tilsvarende hydroksykarbostyril med et tilsvarende alkan som er substituert i a,oo-stilling. Det nødvendige tilsvarende 6-, 7- eller 8-hydroksy-3,4-dihydrokarbostyril får man ved acylering av et tilsvarende anilinderivat med et tilsvarende 3-halogen-karboksylsyrederivat og påfølgende ringslutning ifølge Friedel-Crafts (se J. chem. Soc. 1955, 743-744, Chem. Pharm. Bull 1961, 970-975 og Ber. dtsch. Chem. Ges. 60, 858 (1927)) resp. et 5-hydroksy-3,4-dihydrokarbostyril ved ringslutning av et tilsvarende 2-(3-cyanoetyl)-cykloheksandion-1,3-derivat og påfølgende aromatisering, f.eks. med N-brom-succinimid (se Chem. and Ind. 1970, 1435). Fremstillingen av de nødvendige hydroksy-karbostyriler er kjent fra litteraturen is obtained by reacting a corresponding hydroxycarbostyryl with a corresponding alkane that is substituted in the a,oo position. The necessary corresponding 6-, 7- or 8-hydroxy-3,4-dihydrocarbostyryl is obtained by acylation of a corresponding aniline derivative with a corresponding 3-halocarboxylic acid derivative and subsequent ring closure according to Friedel-Crafts (see J. chem. Soc. 1955 , 743-744, Chem. Pharm. Bull 1961, 970-975 and Ber. dtsch. Chem. Ges. 60, 858 (1927)) resp. a 5-hydroxy-3,4-dihydrocarbostyril by cyclization of a corresponding 2-(3-cyanoethyl)-cyclohexanedione-1,3-derivative and subsequent aromatization, e.g. with N-bromosuccinimide (see Chem. and Ind. 1970, 1435). The production of the necessary hydroxycarbostyrils is known from the literature
(se f.eks. J. Amer. Chem. Soc. 12, 346 (1950) og ibid 16, 2402 (see, e.g., J. Amer. Chem. Soc. 12, 346 (1950) and ibid 16, 2402
(1954) resp. J. Org. Chem. 3^3, 1089 (1968) og ibid 36 , 3493 (1954) or J. Org. Chem. 3^3, 1089 (1968) and ibid 36 , 3493
(1971) ) . (1971) ).
En som utgangsforbindelse anvendt forbindelse med den generelle formel V får man f.eks. ved alkylering av et tilsvarende hydroksy-nitro-benzaldehyd resp. dets acetal eller ester med et tilsvarende halogenid og påfølgende reduksjon av nitrogruppen i nærvær av eddiksyreanhydrid. A compound with the general formula V used as starting compound gives, for example, by alkylation of a corresponding hydroxy-nitro-benzaldehyde resp. its acetal or ester with a corresponding halide and subsequent reduction of the nitro group in the presence of acetic anhydride.
De følgende eksempler skal tjene til å illustrere opp-finnelsen ytterligere. The following examples shall serve to further illustrate the invention.
Eksempel 1 Example 1
6-[ 4- ( 2- pyridylsulfonyl)- butoksy]- 3, 4- dihydrokarbostyril 6-[ 4-( 2- pyridylsulfonyl)- butoxy]- 3, 4- dihydrocarbostyril
a) 2- nitro- 5- hydroksy- kanelsyre- metylester a) 2-nitro-5-hydroxy-cinnamic acid methyl ester
21,0 g 2-nitro-5-hydroksy-kanelsyre (S. N. Chakravarti og 21.0 g of 2-nitro-5-hydroxycinnamic acid (S. N. Chakravarti and
P.L.N. Rao, Chem. Soc. 1938, 172) oppløses i 200 ml metanol og tilsettes dråpevis 86 ml tionylklorid under omrøring i løpet av 45 minutter, hvorved temperaturen stiger til 36°C. Man efter-rører i ytterligere 25 minutter. Efter avkjøling i isbad får man 18,6 g 2-nitro-5-hydroksy-kanelsyremetylester med smeltepunkt 201-203°C. P.L.N. Rao, Chem. Soc. 1938, 172) is dissolved in 200 ml of methanol and 86 ml of thionyl chloride is added dropwise with stirring over the course of 45 minutes, whereby the temperature rises to 36°C. You continue to stir for a further 25 minutes. After cooling in an ice bath, 18.6 g of 2-nitro-5-hydroxycinnamic acid methyl ester with a melting point of 201-203°C is obtained.
b) 2- nitro- 5- brombutoksy- kanelsyre- metylester b) 2-nitro-5-bromobutoxy-cinnamic acid methyl ester
22,3 g 2-nitro-5-hydroksy-kanelsyre-metylester omrøres 22.3 g of 2-nitro-5-hydroxycinnamic acid methyl ester are stirred
med 59,7 ml 1,4-dibrombutan og 13,8 g kaliumkarbonat i 200 ml dimetylsulfoksyd i 15 timer ved romtemperatur, hvorefter 800 ml vann tilsettes. Man ekstraherer med kloroform, og efter avdampning av oppløsningsmidlet isoleres 31,7 g 2-nitro-5-brombutoksy-kanelsyre-metylester med smeltepunkt 60,5-63°C. with 59.7 ml of 1,4-dibromobutane and 13.8 g of potassium carbonate in 200 ml of dimethylsulfoxide for 15 hours at room temperature, after which 800 ml of water is added. It is extracted with chloroform, and after evaporation of the solvent, 31.7 g of 2-nitro-5-bromobutoxycinnamic acid methyl ester with a melting point of 60.5-63°C is isolated.
c) 2- nitro- 5-[ 4-( 2- pyridylmerkapto)- butoksy]- kanelsyre- metylester 10,75 g 2-nitro-5-brombutoksy-kanelsyre-metylester c) 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-cinnamic acid methyl ester 10.75 g 2-nitro-5-bromobutoxy-cinnamic acid methyl ester
settes til en blanding av 5 g kaliumkarbonat og 4,0 g 2-merkaptopyridin i 100 ml dimetylsulfoksyd som på forhånd er omrørt i 60 minutter, og man omrører i 18 timer ved romtemperatur. Man tilsetter 400 ml vann og isolerer det oljeaktige reaksjonsprodukt ved eterekstråksjon. is added to a mixture of 5 g of potassium carbonate and 4.0 g of 2-mercaptopyridine in 100 ml of dimethylsulfoxide which has been stirred for 60 minutes in advance, and is stirred for 18 hours at room temperature. 400 ml of water is added and the oily reaction product is isolated by ether extraction.
Utbytte: 11,0 g (94,2% av det teoretiske). Yield: 11.0 g (94.2% of theoretical).
d) 2- nitro- 5-[ 4- ( 2- pyridylsulfonyl)- butoksy]- kanelsyre- metylester 7,0 g 2-nitro-5-[4-(2-pyridylmerkapto)-butoksy]-kanelsyre-metylester oppløses i 70 ml eddiksyre, tilsettes 5,0 ml 35%ig hydrogenperoksyd og får stå i 3 dager ved romtemperatur. Efter avdestillering av iseddiken omkrystalliserer man produktet fra kloroform/metanol. d) 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid methyl ester Dissolve 7.0 g of 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-cinnamic acid methyl ester in 70 ml of acetic acid, 5.0 ml of 35% hydrogen peroxide is added and allowed to stand for 3 days at room temperature. After distilling off the glacial acetic acid, the product is recrystallized from chloroform/methanol.
Utbytte: 3,5 g (46,2% av det teoretiske), smeltepunkt: 118-121°C. Yield: 3.5 g (46.2% of the theoretical), melting point: 118-121°C.
De ovenstående punkter a)-d) angår fremstilling av utgangs-materiale. The above points a)-d) relate to the production of starting material.
e) 6- [ 4- ( 2- pyridylsulfonyl)- butoksy]- 3, 4- dihydrokarbostyril e) 6- [ 4- ( 2- pyridylsulfonyl)- butoxy]- 3, 4- dihydrocarbostyril
2,1 g 2-nitro-5-[4-(2-pyridylsulfonyl)-butoksy]-kanelsyre-metylester , oppløst i 20 ml iseddik, hydrogeneres med 0,5 g 10%ig palladiumkull ved 3 bar hydrogentrykk og romtemperatur. Derefter avdestilleres iseddiken, og residuet oppvarmes med 20 ml konsentrert saltsyre i 4 timer til kokning under tilbakeløps-kjøling. Efter nøytralisering med 2N natronlut ekstraherer man med kloroform. Avdampningsresiduet omkrystalliseres fra xylen. Utbytte: 1,06 g (55,6% av det teoretiske), smeltepunkt: 121-123°C. 2.1 g of 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid methyl ester, dissolved in 20 ml of glacial acetic acid, is hydrogenated with 0.5 g of 10% palladium charcoal at 3 bar hydrogen pressure and room temperature. The glacial acetic acid is then distilled off, and the residue is heated with 20 ml of concentrated hydrochloric acid for 4 hours to boiling under reflux cooling. After neutralization with 2N caustic soda, extraction is carried out with chloroform. The evaporation residue is recrystallized from xylene. Yield: 1.06 g (55.6% of theory), melting point: 121-123°C.
Eksempel 2 Example 2
6- [ 4- ( 2- pyridylsulfonyl)- butoksy]- karbostyril 6- [ 4- ( 2- pyridylsulfonyl)- butoxy]- carbostyryl
2,0 g 2-nitro-5-[4-(2-pyridylsulfonyl)-butoksy]-kanelsyre-metylester oppvarmes sammen med 3,0 g natriumditionitt i en blanding av 20 ml vann og 10 ml etanol i 4 timer til kokning under tilbakeløpskjøling, hvorved det dannes en klar oppløsning. Reaksjonsblandingen inndampes og oppvarmes med 20 ml konsentrert saltsyre i 3 timer til kokning under tilbakeløpskjøling. Efter nøytralisering med 2N natronlut ekstraheres reaksjonsproduktet med eter og omkrystalliseres fra xylen under tilsetning av litt dimetylformamid. 2.0 g of 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-cinnamic acid methyl ester is heated together with 3.0 g of sodium dithionite in a mixture of 20 ml of water and 10 ml of ethanol for 4 hours to boiling under reflux cooling, whereby a clear solution is formed. The reaction mixture is evaporated and heated with 20 ml of concentrated hydrochloric acid for 3 hours to boiling under reflux. After neutralization with 2N caustic soda, the reaction product is extracted with ether and recrystallized from xylene while adding a little dimethylformamide.
Utbytte: 0,5 g (29% av det teoretiske), smeltepunkt: 176-179°C. Yield: 0.5 g (29% of theoretical), melting point: 176-179°C.
På samme måte kan denne forbindelse fremstilles når man istedenfor natriumditionitt som reduksjonsmiddel anvender hydrogen i nærvær av Lindlar-katalysator (palladium, partielt inaktivert med bly). Derved reduseres bare nitrogruppen, slik at man efter den påfølgende behandling med konsentrert saltsyre får 6-[4-(2-pyridylsulfonyl)-butoksy]-karbostyril. In the same way, this compound can be prepared when, instead of sodium dithionite as reducing agent, hydrogen is used in the presence of a Lindlar catalyst (palladium, partially inactivated with lead). Thereby, only the nitro group is reduced, so that after the subsequent treatment with concentrated hydrochloric acid, 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyril is obtained.
Eksempel 3 Example 3
6-[ 4-( 3, 4- diklorfenylmerkapto)- butoksy]- karbostyril 6-[ 4-( 3, 4- dichlorophenylmercapto)- butoxy]- carbostyryl
4,5 g 2-nitro-5-[4-(3,4-diklorfenylmerkapto)-butoksy]-kanelsyre-metylester (smeltepunkt: 91-92°C; fremstilt fra 2-nitro-5-hydroksy-kanelsyre-metylester og 4-(3,4-diklorfenyl-merkapto) -butylbromid) oppvarmes til kokning under tilbakeløps-kjøling sammen med 13,9 g natriumditionitt i en blanding av 50 ml etanol og 50 ml vann i 4 timer. Derefter avdestillerer man oppløsningsmidlet og koker residuet under tilbakeløpskjøling i 4.5 g of 2-nitro-5-[4-(3,4-dichlorophenylmercapto)-butoxy]-cinnamic acid methyl ester (melting point: 91-92°C; prepared from 2-nitro-5-hydroxy-cinnamic acid methyl ester and 4-(3,4-dichlorophenyl-mercapto)-butyl bromide) is heated to boiling under reflux with 13.9 g of sodium dithionite in a mixture of 50 ml of ethanol and 50 ml of water for 4 hours. The solvent is then distilled off and the residue is boiled under reflux in
4 timer med 100 ml konsentrert saltsyre. Det dannede krystallinske 4 hours with 100 ml of concentrated hydrochloric acid. It formed crystalline
stoff avsuges og omkrystalliseres med xylen. substance is suctioned off and recrystallized with xylene.
Utbytte: 1,2 g (31% av det teoretiske), smeltepunkt: 144°C. Yield: 1.2 g (31% of theoretical), melting point: 144°C.
E ksempel 4 Example 4
6-[ 4- ( 3, 4- diklorfenylsulfonyl)- butoksy]- 3, 4- dihydro- karbostyril 6-[ 4-( 3, 4- dichlorophenylsulfonyl)- butoxy]- 3, 4- dihydro- carbostyryl
I 50 ml absolutt dimetylsulfoksyd omrøres 5,96 g 6-(4-brombutoksy)-3,4-dihydrokarbostyril sammen med 5,53 g kaliumkarbonat og 18,75 g 3,4-diklorfenylsulfinsurt natrium i 24 timer ved romtemperatur. Derefter opptas reaksjonsblandingen i 500 ml eddiksyreetylester, vaskes med vann og tørres over magnesiumsulfat. Ved inndampning av oppløsningen får man det krystallinske reaksjonsprodukt. In 50 ml of absolute dimethylsulfoxide, 5.96 g of 6-(4-bromobutoxy)-3,4-dihydrocarbostyril are stirred together with 5.53 g of potassium carbonate and 18.75 g of 3,4-dichlorophenylsulfinic acid sodium for 24 hours at room temperature. The reaction mixture is then taken up in 500 ml ethyl acetate, washed with water and dried over magnesium sulphate. When the solution is evaporated, the crystalline reaction product is obtained.
Utbytte: 4,65 g (54% av det teoretiske), smeltepunkt: 170-171°C. Yield: 4.65 g (54% of the theoretical), melting point: 170-171°C.
Eksempel 5 Example 5
6-[ 4-( 3, 4- diklorfenyl- sulfinyl)- butoksy]- karbostyril 6-[ 4-( 3, 4- dichlorophenyl- sulfinyl)- butoxy]- carbostyryl
a) 2- nitro- 5-[ 4- ( 3, 4- diklorfenylsulfinyl)- butoksy]- kanelsyre-metylester a) 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester
11,2 g 2-nitro-5-hydroksy-kanelsyre-metylester oppløses 11.2 g of 2-nitro-5-hydroxycinnamic acid methyl ester are dissolved
i 150 ml dimetylsulfoksyd og omrøres med 9,2 g vannfritt kaliumkarbonat i 15 minutter, hvorefter 16,5 g 4-(3,4-diklorfenyl-sulf inyl) -butylbromid tilsettes, og blandingen omrøres i 40 timer ved romtemperatur. Man fortynner med 1000 ml vann og ekstraherer med en blanding av 200 ml kloroform og 100 ml metanol. Efter avdampning av det organiske oppløsningsmiddel blir det tilbake et oljeaktig residuum som efter behandling med eter gjennom-krystalliserer. in 150 ml of dimethyl sulfoxide and stirred with 9.2 g of anhydrous potassium carbonate for 15 minutes, after which 16.5 g of 4-(3,4-dichlorophenyl-sulfinyl)-butyl bromide is added, and the mixture is stirred for 40 hours at room temperature. Dilute with 1000 ml of water and extract with a mixture of 200 ml of chloroform and 100 ml of methanol. After evaporation of the organic solvent, an oily residue remains which, after treatment with ether, crystallizes through.
Utbytte: 13 g (57% av det teoretiske), smeltepunkt: 78-81°C. Yield: 13 g (57% of theoretical), melting point: 78-81°C.
b) 2- amino- 5-[ 4-( 3, 4- diklorfenylsulfinyl)- butoksy]- kanelsyre-metylester b) 2-amino-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester
4,2'g 2-nitro-5-[4- (3,4-diklorfenylsulfinyl)-butoksy]-kanelsyremetylester hydrogeneres i 100 ml metanol med 0,5 g Lindlar-katalysator (palladium på kalsiumkarbonat, partielt ! inaktivert med blyacetat) ved 3 bar og romtemperatur i 12 timer. Efter frafiltrering av katalysatoren avdamper man oppløsningsmidlet og anvender det harpiksaktig, mørke residuum umiddelbart til den påfølgende omsetning. 4.2 g of 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester is hydrogenated in 100 ml of methanol with 0.5 g of Lindlar catalyst (palladium on calcium carbonate, partially inactivated with lead acetate) at 3 bar and room temperature for 12 hours. After filtering off the catalyst, the solvent is evaporated and the resinous, dark residue is used immediately for the subsequent reaction.
c) 6-[ 4-( 3, 4- diklorfenylsulfinyl)- butoksy]- karbostyril c) 6-[ 4-( 3, 4- dichlorophenylsulfinyl)-butoxy]- carbostyryl
Den i foregående trinn beskrevne 2-amino-5-[4-(3,4-diklorfenylsulfinyl)-butoksy]-kanelsyre-metylester oppvarmes med 80 ml 5N saltsyre i 3 timer til kokning og filtreres i varm tilstand. Fra filtratet utskilles farveløse krystaller ved avkjøling. The 2-amino-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester described in the previous step is heated with 80 ml of 5N hydrochloric acid for 3 hours until boiling and filtered while hot. Colorless crystals separate from the filtrate on cooling.
Utbytte: 2,1 g (56% av det teoretiske), smeltepunkt: 191-192°C. Yield: 2.1 g (56% of theoretical), melting point: 191-192°C.
Hvis man ved det ovenfor beskrevne reaksjonsforløp If one knows the reaction sequence described above
for reduksjonen av 2-nitro-5-[4-(3,4-diklorfenylsulfinyl)-butoksy]-kanelsyre-metylester anvender jernpulver og 80%ig eddiksyre som reduksjonsmiddel, får man likeledes 6-[4-(3,4-diklorfenylsulfinyl)-butoksy]-karbostyril som reaksjonsprodukt. for the reduction of 2-nitro-5-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-cinnamic acid methyl ester using iron powder and 80% acetic acid as a reducing agent, 6-[4-(3,4-dichlorophenylsulfinyl) is likewise obtained )-butoxy]-carbostyryl as reaction product.
E ksempel 6 Example 6
2,3 g 2-nitro-5-(3,4-diklorfenylsulfinyl)-butoksy-kanelsyre-metylester hydrogeneres i 20 ml iseddik og 0,3 g palladium/kull ved 3 bar hydrogentrykk og romtemperatur i 7 timer analogt med eksempel 5b. Derefter f raf Utreres katalysatoren, iseddiken avdestilleres, og residuet oppvarmes i 2.3 g of 2-nitro-5-(3,4-dichlorophenylsulfinyl)-butoxy-cinnamic acid methyl ester is hydrogenated in 20 ml of glacial acetic acid and 0.3 g of palladium/charcoal at 3 bar hydrogen pressure and room temperature for 7 hours analogously to example 5b. Then f raf The catalyst is removed, the glacial acetic acid is distilled off, and the residue is heated in
1 time til kokning med 40 ml 5N saltsyre. Efter avkjøling ekstraherer man med litt kloroform og foretar separering ved kromatografi på en tynnskiktplate (Merck silikagel 60 F254^ 1 hour for boiling with 40 ml of 5N hydrochloric acid. After cooling, extract with a little chloroform and separate by chromatography on a thin-layer plate (Merck silica gel 60 F254^
med etylenklorid/metanol = 9:1. Identifiseringen av de dannede forbindelser ble foretatt i UV-lys og ved besprøytning med en jod-dusj. with ethylene chloride/methanol = 9:1. The identification of the compounds formed was carried out in UV light and by spraying with an iodine shower.
Rf-verdi: 0,30: 6-[4-(3,4-diklorfenylsulfinyl)-butoksy]-karbostyril, med jod-dusj blåfiolett. Rf value: 0.30: 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl, with iodine shower blue violet.
Rf-verdi: 0,42: 6-[4-(3,4-diklorfenylmerkapto)-butoksy]-karbostyril, med jod-dusj først oransjegul, derefter gradvis gråfiolett. Rf value: 0.42: 6-[4-(3,4-dichlorophenylmercapto)-butoxy]-carbostyril, with iodine shower first orange-yellow, then gradually grey-violet.
Rf-verdi: 0,45: 6-[4-(3,4-diklorfenylsulfinyl)-butoksy]-3,4-dihydro-karbostyril, med jod-dusj kraftig oransjegul. Rf value: 0.45: 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-3,4-dihydro-carbostyril, with iodine shower strong orange-yellow.
Rf-verdi: 0,57: 6-[4-(3,4-diklorfenylmerkapto)-butoksy]-3,4-dihydro-karbostyril, med jod-dusj lys egg-gul. Rf value: 0.57: 6-[4-(3,4-dichlorophenylmercapto)-butoxy]-3,4-dihydro-carbostyril, with iodine shower light egg-yellow.
Eksempel 7 Example 7
6- [ 4-( 2- pyridylsulfonyl)- butoksy]- karbostyril 6- [ 4-( 2- pyridylsulfonyl)- butoxy]- carbostyryl
a) 2- nitro- 5-( 4- brombutoksy)- benzaldehyd a) 2-nitro-5-(4-bromobutoxy)-benzaldehyde
14,4 g 2-nitro-5-hydroksybenzaldehydkarbonat [F.A. Mason, 14.4 g of 2-nitro-5-hydroxybenzaldehyde carbonate [F.A. Mason,
J. Chem. Soc. 127, 119 7 (19 25)] omrøres sammen med 40 ml dibrombutan og 24 g vannfritt kaliumkarbonat i 140 ml dimetylsulfoksyd ved romtemperatur i 4 timer. Derefter fortynner man med 800 ml vann og ekstraherer reaksjonsproduktet med kloroform. Det oljeaktige avdampningsresiduum oppsluttes flere ganger med petrol-eter for å fjerne overskudd av dibrombutan. Det gjenværende oljeaktige 2-nitro-5-(4-brombutoksy)-benzaldehyd (21 g) anvendes videre i rå tilstand. J. Chem. Soc. 127, 119 7 (19 25)] is stirred together with 40 ml of dibromobutane and 24 g of anhydrous potassium carbonate in 140 ml of dimethyl sulphoxide at room temperature for 4 hours. It is then diluted with 800 ml of water and the reaction product is extracted with chloroform. The oily evaporation residue is washed several times with petroleum ether to remove excess dibromobutane. The remaining oily 2-nitro-5-(4-bromobutoxy)-benzaldehyde (21 g) is further used in the crude state.
Rf-verdi: 0,75 (tynnskiktplate (Merck silikagel 60 F 254), utviklingsmiddel: etylenklorid/metanol = 9:1). Rf value: 0.75 (thin layer plate (Merck silica gel 60 F 254), developer: ethylene chloride/methanol = 9:1).
b) 2- nitro- 5-[ 4-( 2- pyridylmerkapto)- butoksy]- benzaldehyd b) 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-benzaldehyde
21 g av det rå 2-nitro-5-(4-brombutoksy)-benzaldehyd 21 g of the crude 2-nitro-5-(4-bromobutoxy)-benzaldehyde
omrøres sammen med 11,6 g 2-merkaptopyridin og 20 g vannfritt kaliumkarbonat i 6 timer ved romtemperatur i 100 ml dimetylsulfoksyd. Man fortynner med 500 ml vann, ekstraherer med kloroform og fjerner det organiske oppløsningsmiddel i vakuum. is stirred together with 11.6 g of 2-mercaptopyridine and 20 g of anhydrous potassium carbonate for 6 hours at room temperature in 100 ml of dimethyl sulfoxide. Dilute with 500 ml of water, extract with chloroform and remove the organic solvent in vacuo.
c) 2- acetamino- 5-[ 4-( 2- pyridylsulfonyl)- butoksy]- benzaldehyd-diacetat c) 2-acetamino-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde diacetate
6,6 g av det rå 2-nitro-5-[4-(2-pyridylmerkapto)-butoksy]-benzaldehyd oppvarmes sammen med 3 ml eddiksyreanhydrid og 0,01 g vannfritt sinkklorid i 30 minutter til kokning, avkjøles og omrøres med 60 ml iseddik og 2,5 g 35%ig hydrogenperoksyd i 15 timer ved romtemperatur. Reaksjonsblandingen hydrogeneres derefter i et Parr-apparat under tilsetning av 0,1 g palladium/kull ved 3 bar hydrogentrykk i 11 timer ved romtemperatur. For acetylering av den dannede aminoforbindelse inndampes reaksjonsblandingen i vakuum til tørrhet, oppvarmes påny med 20 ml eddiksyreanhydrid i 30 minutter til kokning, og blandingen av overskudd av eddiksyreanhydrid og iseddik avdestilleres. 6.6 g of the crude 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-benzaldehyde are heated together with 3 ml of acetic anhydride and 0.01 g of anhydrous zinc chloride for 30 minutes to boiling, cooled and stirred with 60 ml of glacial acetic acid and 2.5 g of 35% hydrogen peroxide for 15 hours at room temperature. The reaction mixture is then hydrogenated in a Parr apparatus with the addition of 0.1 g palladium/coal at 3 bar hydrogen pressure for 11 hours at room temperature. For acetylation of the amino compound formed, the reaction mixture is evaporated in vacuo to dryness, reheated with 20 ml of acetic anhydride for 30 minutes until boiling, and the mixture of excess acetic anhydride and glacial acetic acid is distilled off.
d) 6-[ 4-( 2- pyridylsulfonyl)- butoksy]- karbostyril d) 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyryl
Det ifølge eksempel c) erholdte destillasjonsresiduum The distillation residue obtained according to example c).
oppvarmes med 20 ml eddiksyreanhydrid og 5 g vannfritt kaliumacetat i 14 timer til kokning. Efter avkjøling tilsetter man 20 ml vann og lar blandingen stå natten over. Det utskilles farveløse krystaller. heated with 20 ml of acetic anhydride and 5 g of anhydrous potassium acetate for 14 hours until boiling. After cooling, add 20 ml of water and let the mixture stand overnight. Colorless crystals are excreted.
Utbytte: 2,9 g (41% av det teoretiske), smeltepunkt: 178-179°C. Yield: 2.9 g (41% of theoretical), melting point: 178-179°C.
Eksempel 8 Example 8
6- [ 4- ( 2- pyridylsulfonyl)- butoksy]- karbostyril 6- [ 4- ( 2- pyridylsulfonyl)- butoxy]- carbostyryl
a) 2- nitro- 5-[ 4-( 2- pyridylsulfonyl)- butoksy]- benzaldehyd a) 2-nitro-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde
1,0 g av det ifølge eksempel 7b) erholdte 2-nitro-5-[4-(2-pyridylmerkapto)-butoksy]-benzaldehyd oppløses i 100 ml iseddik, tilsettes 1,0 ml 35%ig hydrogenperoksyd og omrøres i 60 timer ved romtemperatur. Man fortynner med 200 ml vann, ekstraherer med kloroform/metanol = 2:1 og får efter inndampning en olje. Utbytte: 1 g (91% av det teoretiske), 1.0 g of the 2-nitro-5-[4-(2-pyridylmercapto)-butoxy]-benzaldehyde obtained according to example 7b) is dissolved in 100 ml of glacial acetic acid, 1.0 ml of 35% hydrogen peroxide is added and stirred for 60 hours at room temperature. It is diluted with 200 ml of water, extracted with chloroform/methanol = 2:1 and, after evaporation, an oil is obtained. Yield: 1 g (91% of theoretical),
R^-verdi: 0,17 (silikagel-lysstoffplate Merck 60 F254' utviklingsmiddel: cykloheksan/etylacetat = 1:2). R^ value: 0.17 (silica gel fluorescent plate Merck 60 F254' developer: cyclohexane/ethyl acetate = 1:2).
b) 2- amino- 5-[ 4-( 2- pyridylsulfonyl)- butoksy]- benzaldehyd b) 2-amino-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde
Den under a) erholdte olje reduseres med jern(II)-sulfat-heptahydrat/kons. vandig ammoniakk ved 90°C. The oil obtained under a) is reduced with iron (II) sulfate heptahydrate/conc. aqueous ammonia at 90°C.
c) 6-[ 4-( 2- pyridylsulfonyl)- butoksy]- karbostyril c) 6-[4-(2-pyridylsulfonyl)-butoxy]-carbostyryl
Det under b) erholdte 2-amino-5-[4-(2-pyridylsulfonyl)-butoksy]-benzaldehyd acetyleres med eddiksyreanhydrid/pyridin, opptas pånytt i eddiksyreanhydrid og oppvarmes med vannfritt kaliumacetat i 5 timer ved kokning under tilbakeløpskjøling. Man fortynner med vann efter avkjøling og ekstraherer med kloroform/metanol = 2:1. Inndampningsresiduet krystalliserer efter en tid. Omkrystallisering foretas fra xylen under tilsetning av litt dimetylformaldehyd. The 2-amino-5-[4-(2-pyridylsulfonyl)-butoxy]-benzaldehyde obtained under b) is acetylated with acetic anhydride/pyridine, taken up again in acetic anhydride and heated with anhydrous potassium acetate for 5 hours by boiling under reflux. Dilute with water after cooling and extract with chloroform/methanol = 2:1. The evaporation residue crystallizes after some time. Recrystallization is carried out from xylene with the addition of a little dimethylformaldehyde.
Smeltepunkt: 179-181°C. Melting point: 179-181°C.
Analogt med de ovenstående eksempler ble følgende forbindelser fremstilt: 6-(4-fenylmerkapto-butoksy)-3,4-dihydrokarbostyril, smeltepunkt: 121,5-12 3°C 6-(4-fenylsulfinylbutoksy)-3,4-dihydrokarbostyril, smeltepunkt: 144,5-145,5°C, Analogous to the above examples, the following compounds were prepared: 6-(4-phenylmercapto-butoxy)-3,4-dihydrocarbostyril, melting point: 121.5-12 3°C 6-(4-phenylsulfinylbutoxy)-3,4-dihydrocarbostyryl, melting point: 144.5-145.5°C,
6-(4-fenylsulfonylbutoksy)-3,4-dihydrokarbostyril, smeltepunkt: 157,5-158°C, 6-(4-phenylsulfonylbutoxy)-3,4-dihydrocarbostyryl, melting point: 157.5-158°C,
6-[4-(2-pyridylmerkapto)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 123-124,5°C, 6-[4-(2-pyridylmercapto)-butoxy]-3,4-dihydrocarbostyryl, melting point: 123-124.5°C,
6-[4-(2-pyridylsulfiny1)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 144,5-146°C, 6-[4-(2-pyridylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 144.5-146°C,
6-[4-(2-pyridylsulfonyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 123,8-125°C, 6-[4-(2-pyridylsulfonyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 123.8-125°C,
6-(2-fenylsulfinyl-etoksy)-3,4-dihydrokarbostyril, smeltepunkt: 171-172°C, 6-(2-phenylsulfinyl-ethoxy)-3,4-dihydrocarbostyril, melting point: 171-172°C,
6-(4-benzylsulfiny1-butoksy)-3,4-dihydrokarbostyril, smeltepunkt: 141,5-142°C, 6-(4-benzylsulfinyl-butoxy)-3,4-dihydrocarbostyryl, melting point: 141.5-142°C,
6-[4-(4-klorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 148-149,5°C, 6-[4-(4-chlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 148-149.5°C,
6-(4-cykloheksylsulfiny1-butoksy)-3,4-dihydrokarbostyril, smeltepunkt: 153-155,5°C, 6-(4-cyclohexylsulfinyl-1-butoxy)-3,4-dihydrocarbostyryl, melting point: 153-155.5°C,
6-[4-(2-naftylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 147,5-148,5°C, 6-[4-(2-naphthylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 147.5-148.5°C,
6-[4-(2-metoksyfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 130,5-133°C, 6-[4-(2-Methoxyphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyril, melting point: 130.5-133°C,
6- (4-fenylsulfiny1-butoksy)-karbostyril, 6-(4-phenylsulfinyl-1-butoxy)-carbostyryl,
smeltepunkt: 181-182,5°C, melting point: 181-182.5°C,
6-[4-(4-hydroksy-3,5-di-tert.butyl-fenylsulfinyl)-butoksy]karbostyril 6-[4-(4-hydroxy-3,5-di-tert.butyl-phenylsulfinyl)-butoxy]carbostyryl
smeltepunkt: 19 2-19 4°C, melting point: 19 2-19 4°C,
6-[4-(3,4-dikiorfenylsulfinyl)-butoksy]-karbostyril, smeltepunkt: 191-196°C, 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-carbostyryl, melting point: 191-196°C,
4-metyl-6-(4-fenylsulfiny1-butoksy)-karbostyril, 4-methyl-6-(4-phenylsulfinyl-butoxy)-carbostyril,
smeltepunkt: 167-168°C, melting point: 167-168°C,
6-[4-(3,4-diklorfenylsulfony1)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 172-173°C, 6-[4-(3,4-dichlorophenylsulfonyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 172-173°C,
6-[4-(2,5-diklorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 185-186°C, 6-[4-(2,5-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 185-186°C,
6-[4-(2-pyridyl)-sulfony1-butoksy]-karbostyril, 6-[4-(2-pyridyl)-sulfony-1-butoxy]-carbostyryl,
smeltepunkt: 179-180°C, melting point: 179-180°C,
6-[4-(2-naftyl-sulfinyl)-butoksy]-3,4-dihydro-karbostyril, smeltepunkt: 147,5-148,5°C, 6-[4-(2-naphthyl-sulfinyl)-butoxy]-3,4-dihydro-carbostyryl, melting point: 147.5-148.5°C,
6- [4- (4-bifenylylsulfinyl)-butoksy]-karbostyril, 6-[4-(4-biphenylylsulfinyl)-butoxy]-carbostyryl,
smeltepunkt: 196-197°C, melting point: 196-197°C,
6-[4-(2-kinolylsulfinyl)-butoksy]-karbostyril, 6-[4-(2-quinolylsulfinyl)-butoxy]-carbostyril,
smeltepunkt: 19 7-19 8°C, melting point: 19 7-19 8°C,
6- [4-cykloheksylsulfinyl)-butoksy]-karbostyril, 6-[4-cyclohexylsulfinyl)-butoxy]-carbostyryl,
smeltepunkt: 169-170°C, melting point: 169-170°C,
5- brom-6-(4-fenylsulfiny1-butoksy)-karbostyril, 5-bromo-6-(4-phenylsulfinyl-butoxy)-carbostyryl,
smeltepunkt: 190-191°C, melting point: 190-191°C,
6- [2-(N-metyl-N-cykloheksyl-karbamidometyl-sulfinyl)-etoksy]-karbostyril, 6-[2-(N-methyl-N-cyclohexyl-carbamidomethyl-sulfinyl)-ethoxy]-carbostyryl,
smeltepunkt: 123-130°C, melting point: 123-130°C,
6-[4-(3,5-dibrom-4-aminofenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril , 6-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl,
smeltepunkt: 144-146°C, melting point: 144-146°C,
6-[4-(3,5-dibrom-4-aminofenylsulfinyl)-butoksy]-karbostyril, smeltepunkt: 205-207°C, 6-[4-(3,5-dibromo-4-aminophenylsulfinyl)-butoxy]-carbostyryl, melting point: 205-207°C,
6- [4- (3,4-cykloheksylfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, 6-[4-(3,4-cyclohexylphenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl,
smeltepunkt: 155-157°C, melting point: 155-157°C,
6-[4-(4-cykloheksylfenylsulfinyl)-butoksy]-karbostyril, smeltepunkt: 188-190°C, 6-[4-(4-cyclohexylphenylsulfinyl)-butoxy]-carbostyryl, melting point: 188-190°C,
6-[4-(4-tert.butylfenylsulfinyl)-butoksy]-karbostyril,• smeltepunkt: 16 4-16 6°C, 6-[4-(4-tert.butylphenylsulfinyl)-butoxy]-carbostyryl,• melting point: 16 4-16 6°C,
6- [4- (3,4-diklorfenylsulfinyl)-butoksy]-3,4-dihydrokarbostyril, smeltepunkt: 106,5-108°C, 6-[4-(3,4-dichlorophenylsulfinyl)-butoxy]-3,4-dihydrocarbostyryl, melting point: 106.5-108°C,
smeltepunkt: 148-149°C ( 1 x fra toluen og 1 x fra etanol). melting point: 148-149°C (1 x from toluene and 1 x from ethanol).
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792928583 DE2928583A1 (en) | 1979-07-14 | 1979-07-14 | Substd. alkoxy-carbostyril derivs prodn. - e.g. by cyclising 2-carboxyethyl-1-aminobenzene derivs., useful as antithrombotic and positive inotropic agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO792659L NO792659L (en) | 1981-01-15 |
NO154131B true NO154131B (en) | 1986-04-14 |
NO154131C NO154131C (en) | 1986-07-23 |
Family
ID=6075786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO792659A NO154131C (en) | 1979-07-14 | 1979-08-15 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5616470A (en) |
DE (1) | DE2928583A1 (en) |
DK (1) | DK150156C (en) |
FI (1) | FI70408C (en) |
NO (1) | NO154131C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI77852C (en) * | 1981-02-17 | 1989-05-10 | Otsuka Pharma Co Ltd | Process for the preparation of novel, such as cardiac drugs, useful s unsubstituted amide and (saturated heterocycle) carbonyl carbostyril derivatives. |
US4442111A (en) * | 1981-07-25 | 1984-04-10 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Antithrombotic sulfimino and sulfoximino indolinones-2 |
AU532361B2 (en) * | 1981-09-01 | 1983-09-29 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
DK167187A (en) * | 1986-04-02 | 1987-10-03 | Otsuka Pharma Co Ltd | CARBOSTYRIC DERIVATIVES AND SALTS THEREOF, PROCEDURE FOR THE PREPARATION OF SUCH COMPOUNDS AND MEDICINAL CONTAINING THESE |
KR940000785B1 (en) * | 1986-04-02 | 1994-01-31 | 오오쓰까세이야꾸 가부시끼가이샤 | Process for the preparation of carbostyril derivatives and salts thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5321176A (en) * | 1976-08-09 | 1978-02-27 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
-
1979
- 1979-07-14 DE DE19792928583 patent/DE2928583A1/en not_active Withdrawn
- 1979-08-03 FI FI792426A patent/FI70408C/en not_active IP Right Cessation
- 1979-08-15 DK DK342079A patent/DK150156C/en not_active IP Right Cessation
- 1979-08-15 NO NO792659A patent/NO154131C/en unknown
-
1980
- 1980-05-26 JP JP6999180A patent/JPS5616470A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
DK150156C (en) | 1987-10-12 |
NO154131C (en) | 1986-07-23 |
NO792659L (en) | 1981-01-15 |
FI70408B (en) | 1986-03-27 |
FI70408C (en) | 1986-09-19 |
FI792426A (en) | 1981-01-15 |
DE2928583A1 (en) | 1981-01-29 |
JPS6326751B2 (en) | 1988-05-31 |
DK342079A (en) | 1981-01-15 |
DK150156B (en) | 1986-12-22 |
JPS5616470A (en) | 1981-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4066651A (en) | Alkanoic acid 2-quinoline derivatives | |
PL170726B1 (en) | Method of obtaining 2-substituted quinolines | |
NO154131B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. | |
NO164351B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ALKYL-L-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS. | |
JPH0692371B2 (en) | Novel heterocyclic derivative, method for producing the same, and method for producing a medicine containing these and particularly useful as an aldose reductase inhibitor | |
CS236876B2 (en) | Processing of new dibenzoxazine | |
NO158185B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,5-DIFENYLPYRAZOLINE-3-ON COMPOUNDS. | |
NO814468L (en) | TIAZOLINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, THEIR USE, AND PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS | |
US2558211A (en) | Preparation of 4-hydroxyquinoline compounds | |
US4138490A (en) | Analgesic compositions containing 1,2-dihydro-2-oxoquinol-4-ylpropionic acid derivatives | |
US4555513A (en) | 1,2 Dihydro- and 1,2,3,4-tetrahydro quinolylacetic acids and analgesic use thereof | |
NO158184B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 1-PHENYLINDAZOL-3-ON COMPOUNDS AND THEIR SALTS. | |
US2139570A (en) | Thiazole compounds and manufacture thereof | |
US2554186A (en) | Para-amino hydroxybenzamides | |
US2996512A (en) | Therapeutic derivatives of aryl- | |
Unangst et al. | 2‐Indolyl ketone synthesis | |
US2187847A (en) | Condensation products of butyrolactones and primary amines of the aromatic and heterocyclic series | |
LEVITZ et al. | The Search for Superior Drugs for Tropical Diseases. I. Derivatives of Quininaldehyde and 6, 7-Dimethoxycinchoninaldehyde | |
KR840002103B1 (en) | Process for preparing carbostyril derivatives | |
Devereux et al. | N-Substituted imides. ii. Potassium Naphthalimide as a Reagent for the identification of Alkyl Halides | |
Allen et al. | Heterocyclic fluorine compounds. Part II. Bz-Monofluoroindoles | |
Souza et al. | On the application of knoevenagel condensation for the synthesis of benzylidene benzothiazine compounds and structural study | |
US2030373A (en) | Derivatives of thiazole and process of preparing the same | |
NO125927B (en) | ||
US2695297A (en) | N-pyridoxyl-amines |